• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic.
SAN DIEGO, April 25, 2024 Cibus, Inc. , a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits in seeds, today announced that the.
HC Wainwright restated their buy rating on shares of Cibus (NASDAQ:CBUS – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $25.00 target price on the stock. Cibus Stock Up 5.3 % Shares of NASDAQ:CBUS opened at $21.45 on Friday. The company has a 50 day moving average of $18.13 […]
SAN DIEGO, March 13, 2024 Cibus, Inc. , a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits in seeds, today announced that Rory.
EU loosens rules for new genomic techniques | The Western Producer producer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from producer.com Daily Mail and Mail on Sunday newspapers.